Drug intelligence / Profile preview

Ad.E7

Development stage
Preclinical
Lead developer
University of Pennsylvania
Modality
Viral Vectors → Gene Addition/Replacement → Gene Therapies, Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

Ad.E7 is an adenoviral-based cancer vaccine designed to elicit a targeted immune response against the Human Papillomavirus (HPV) E7 oncoprotein. The vaccine utilizes a replication-deficient adenoviral vector to deliver the E7 gene into host cells, where the protein is expressed and presented to the immune system. This process induces the expansion of functionally active, E7-specific CD8+ T cells that infiltrate tumors and exhibit cytotoxic activity against cells expressing the viral antigen. Preclinical research has demonstrated its potential in controlling local tumor growth and improving survival in models of HPV-associated malignancies, including esophageal cancer.

Other names
Adenoviral-E7 vaccineAdenoviral-E-7 vaccineAdenoviral-E 7 vaccineAd-HPV16E7Ad-HPV-16E7Ad-HPV 16E7HPV E7 adenoviral vaccine
02

Targets

HPV16 E7 (Human papillomavirus 16 E7 protein)

Beyond the preview

Go deeper on Ad.E7.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ad.E7.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call